Investors Pivot from AI to Healthcare Stocks

Moderna shares pushed higher, extending their recent winning streak. Investors are betting that the vaccine manufacturer’s aggressive push to diversify its product portfolio will eventually yield significant returns.

Roche Holding bolstered sentiment by announcing that a late-stage study of a new lung cancer drug outperformed current standard therapies for patients who have already undergone prior treatment. Meanwhile, the French biotech firm Abivax saw its stock climb after expanding a planned offering. The move follows encouraging clinical trial results for its ulcerative colitis candidate, with analysts at Stifel citing the data as a primary driver of sustained investor appetite.